Search research articles
Contact Us
Filters
Showing results (21-30 of 126) with videos related to
Page
of 13
Sort By:
Neurology
|
August 5, 2020
Author response: Degree of serotonin reuptake inhibition of antidepressants and ischemic risk: A cohort study
Antonios Douros, Jean-Francois Boivin, Christel Renoux
British Journal of Clinical Pharmacology
|
January 4, 2021
Trends in new prescription of gabapentinoids and of coprescription with opioids in the 4 nations of the UK, 1993-2017
Alvi Rahman, Joseph Kane, François Montastruc, et al.
Pharmacoepidemiology and Drug Safety
|
October 7, 2017
Patterns of long-term use of non-vitamin K antagonist oral anticoagulants for non-valvular atrial fibrillation: Quebec observational study
Antonios Douros, Christel Renoux, Janie Coulombe, et al.
Annals of Internal Medicine
|
March 4, 2024
Web Exclusive. Annals On Call - Gabapentinoids and COPD: Not a Good Mix?
Robert M Centor, Alvi A Rahman, Christel Renoux
Epidemiology (Cambridge, Mass.)
|
January 14, 2011
Time-window bias in case-control studies: statins and lung cancer
Samy Suissa, Sophie Dell'aniello, Sarah Vahey, et al.
BMC Neurology
|
October 2, 2012
Pramipexole use and the risk of pneumonia
Pierre Ernst, Christel Renoux, Sophie Dell'Aniello, et al.
Stroke
|
March 21, 2024
Effectiveness and Safety of Edoxaban Compared With Apixaban in Elderly Patients With Nonvalvular Atrial Fibrillation: A Real-World Population-Based Cohort Study
Richard Chiv, Sarah Beradid, Samy Suissa, et al.
BMJ (Clinical Research Ed.)
|
June 8, 2010
Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study
Christel Renoux, Sophie Dell'aniello, Edeltraut Garbe, et al.
Breast Cancer Research and Treatment
|
April 12, 2011
The use of atypical antipsychotics and the risk of breast cancer
Laurent Azoulay, Hui Yin, Christel Renoux, et al.
Pharmacoepidemiology and Drug Safety
|
March 23, 2017
Bias from depletion of susceptibles: the example of hormone replacement therapy and the risk of venous thromboembolism
Christel Renoux, Sophie Dell'Aniello, Benjamin Brenner, et al.
Page
of 13
Search research articles
Search
Showing results (21-30 of 126) with videos related to
Sort By:
Page
of 13
Neurology
|
August 5, 2020
Author response: Degree of serotonin reuptake inhibition of antidepressants and ischemic risk: A cohort study
Antonios Douros, Jean-Francois Boivin, Christel Renoux
British Journal of Clinical Pharmacology
|
January 4, 2021
Trends in new prescription of gabapentinoids and of coprescription with opioids in the 4 nations of the UK, 1993-2017
Alvi Rahman, Joseph Kane, François Montastruc, et al.
Pharmacoepidemiology and Drug Safety
|
October 7, 2017
Patterns of long-term use of non-vitamin K antagonist oral anticoagulants for non-valvular atrial fibrillation: Quebec observational study
Antonios Douros, Christel Renoux, Janie Coulombe, et al.
Annals of Internal Medicine
|
March 4, 2024
Web Exclusive. Annals On Call - Gabapentinoids and COPD: Not a Good Mix?
Robert M Centor, Alvi A Rahman, Christel Renoux
Epidemiology (Cambridge, Mass.)
|
January 14, 2011
Time-window bias in case-control studies: statins and lung cancer
Samy Suissa, Sophie Dell'aniello, Sarah Vahey, et al.
BMC Neurology
|
October 2, 2012
Pramipexole use and the risk of pneumonia
Pierre Ernst, Christel Renoux, Sophie Dell'Aniello, et al.
Stroke
|
March 21, 2024
Effectiveness and Safety of Edoxaban Compared With Apixaban in Elderly Patients With Nonvalvular Atrial Fibrillation: A Real-World Population-Based Cohort Study
Richard Chiv, Sarah Beradid, Samy Suissa, et al.
BMJ (Clinical Research Ed.)
|
June 8, 2010
Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study
Christel Renoux, Sophie Dell'aniello, Edeltraut Garbe, et al.
Breast Cancer Research and Treatment
|
April 12, 2011
The use of atypical antipsychotics and the risk of breast cancer
Laurent Azoulay, Hui Yin, Christel Renoux, et al.
Pharmacoepidemiology and Drug Safety
|
March 23, 2017
Bias from depletion of susceptibles: the example of hormone replacement therapy and the risk of venous thromboembolism
Christel Renoux, Sophie Dell'Aniello, Benjamin Brenner, et al.
Page
of 13